Teligent Total Current Assets 2010-2021 | TLGT
Teligent total current assets from 2010 to 2021. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Teligent Annual Total Current Assets
(Millions of US $) |
| 2020 |
$44 |
| 2019 |
$62 |
| 2018 |
$48 |
| 2017 |
$59 |
| 2016 |
$103 |
| 2015 |
$117 |
| 2014 |
$177 |
| 2013 |
$11 |
| 2012 |
$6 |
| 2011 |
$6 |
| 2010 |
$7 |
| 2009 |
$3 |
Teligent Quarterly Total Current Assets
(Millions of US $) |
| 2021-06-30 |
$52 |
| 2021-03-31 |
$61 |
| 2020-12-31 |
$44 |
| 2020-09-30 |
$54 |
| 2020-06-30 |
$54 |
| 2020-03-31 |
$52 |
| 2019-12-31 |
$62 |
| 2019-09-30 |
$52 |
| 2019-06-30 |
$48 |
| 2019-03-31 |
$46 |
| 2018-12-31 |
$48 |
| 2018-09-30 |
$51 |
| 2018-06-30 |
$50 |
| 2018-03-31 |
$47 |
| 2017-12-31 |
$59 |
| 2017-09-30 |
$80 |
| 2017-06-30 |
$95 |
| 2017-03-31 |
$102 |
| 2016-12-31 |
$103 |
| 2016-09-30 |
$107 |
| 2016-06-30 |
$111 |
| 2016-03-31 |
$118 |
| 2015-12-31 |
$117 |
| 2015-09-30 |
$163 |
| 2015-06-30 |
$173 |
| 2015-03-31 |
$178 |
| 2014-12-31 |
$177 |
| 2014-09-30 |
$34 |
| 2014-06-30 |
$11 |
| 2014-03-31 |
$10 |
| 2013-12-31 |
$11 |
| 2013-09-30 |
$7 |
| 2013-06-30 |
$6 |
| 2013-03-31 |
$6 |
| 2012-12-31 |
$6 |
| 2012-09-30 |
$4 |
| 2012-06-30 |
$5 |
| 2012-03-31 |
$5 |
| 2011-12-31 |
$6 |
| 2011-09-30 |
$6 |
| 2011-06-30 |
$6 |
| 2011-03-31 |
$7 |
| 2010-12-31 |
$7 |
| 2010-09-30 |
$2 |
| 2010-06-30 |
$3 |
| 2010-03-31 |
$4 |
| 2009-12-31 |
$3 |
| 2009-09-30 |
$4 |
| 2009-06-30 |
$5 |
| 2009-03-31 |
$6 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
